
News|Videos|December 9, 2015
Role of Platelet Aggregation Inhibitors in ACS Management
Katie Greenlee, PharmD, BCPS-AQ Cardiology, of the Cleveland Clinic discusses the role of platelet aggregation inhibitors in ACS management.
Advertisement
Katie Greenlee, PharmD, BCPS-AQ Cardiology, of the Cleveland Clinic discusses the role of platelet aggregation inhibitors in ACS management.
This video was recorded at the 2015 American Society of Health-System Pharmacists Midyear Meeting.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
Enlicitide Meaningfully Lowers LDL-C at 24 Weeks in Patients At Risk for ASCVD Events
3
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
4
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
5


























